Activity and expression of four major protein serine/threonine (Ser/Thr) phosphatases, protein phosphatase type 1 (PP1), protein phosphatase type 2A (PP2A), protein phosphatase type 2B (PP2B) and protein phosphatase type 2C (PP2C) were evaluated in normal peripheral leukocytes, and in various leukemic cells from patients with acute myelogenous leukemia (AML), common acute lymphocytic leukemia (cALL), or chronic lymphocytic leukemia (CLL). PP1 was the most abundant phosphatase in blood cells, and relative abundance of each phosphatase was: PP1ϾPP2AϾPP2BԼPP2C. PP1 activity and its expressions were higher in blasts of AML-M4 and -M5 than in cells of AML-M1, cALL and CLL. PP2A activity and its expression were higher in blasts of AML-M3, -M4 and -M5 than in cells of AML-M1, cALL and CLL. Activity and expression of both PP1 and PP2A in normal monocytes were highest, and PP2A activity in normal neutrophils was lowest among normal leukocytes. PP2B activity and its expression were higher in blasts of AML-M2, -M3 and normal lymphocytes. PP2C activity and its expression were relatively constant in various leukemic cell types. Activities of PP1 and PP2A of AML blasts correlated positively with the expression of CD11b, whereas activities of PP1 and PP2B correlated negatively with the expression of CD7. Thus, each phosphatase was ubiquitously but differently expressed in various leukemic cell types and in normal leukocytes. These data also suggest that expressions of PP1, PP2A and PP2B are relatively low in leukemic blasts arresting at the stage of early pluripotent stem cells, and are differently modulated during the course of myelomonocytic commitment and maturation. Keywords: protein phosphatase type 1; protein phosphatase type 2A; protein phosphatase type 2B (calcineurin); protein phosphatase type 2C; human primary leukemic cells
Introduction
Protein phosphatases, which functionally counteract protein kinases, control a wide range of events such as cell division, cell signalling, cell motility, gene transcription, apoptosis, cell proliferation, differentiation and carcinogenesis. [1] [2] [3] The major protein Ser/Thr phosphatase catalytic subunits of mammalian cells comprise four forms which have been designated PP1, PP2A, PP2B (calcineurin), and PP2C, based on their substrate specificity, dependence on metal ions and sensitivity to inhibitory agents.
1 PP1 and PP2A seem to have no absolute requirement for divalent cations, whereas PP2B and PP2C are Ca 2+ -and Mg 2+ -dependent, respectively. Protein phosphatases may be involved in the processes of differentiation and proliferation of human myeloid leukemia cell line HL-60 cells, in addition to protein kinases. 4 HL-60 cells can be induced to differentiate into monocytes by 1␣,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), or into granulocytes by all-trans retinoic acid (ATRA) and Me 2 SO; terminal differentiation is usually associaCorrespondence: M Mishikawa, 2nd Department of Internal Medicine, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan; Fax: 81 59 231 5200 Received 16 September 1998; accepted 17 December 1998 ted with cessation of cell proliferation. 5 We reported that okadaic acid (OKA) and calyculin-A, potent inhibitors of PP1 and PP2A, augmented either ATRA-induced granulocytic or 1,25(OH) 2 D 3 -induced monocytic differentiation of HL-60 cells. 6 ATRA induces downregulation of the PP2A catalytic subunit in HL-60 cells, whereas PP1 expression is unchanged. [7] [8] [9] We also found that PP1 catalytic subunit isozymes have a differential distribution and translocation during 1,25(OH) 2 D 3 -induced monocytic differentiation. 10 1,25 (OH) 2 D 3 induces upregulation of both PP2B and PP2C in HL-60 cells. 11, 12 ATRA also induces upregulation of PP2B in HL-60 cells, while the PP2C expression is unaltered. 13 Thus, levels of both activity and expression of each protein phosphatase either increase or decrease during HL-60 cell differentiation.
The role and expression of each protein phosphatase have yet to be clarified with regard to blast cells from patients with various types of primary leukemia, and in normal mature leukocytes. Leukemic cells likely arise from a clonal expansion of cells after transformation and arrest at a certain stage of differentiation. 14 We analyzed activities and enzyme expressions of protein Ser/Thr phosphatases in adult human primary leukemic cells, the objective being to evaluate cell type-or lineage-specific expression.
Materials and methods

Cells
Leukemic cells from 85 adult Japanese patients (65, 8 and 12 cases of AML, cALL and B-CLL, respectively) referred to our laboratory between 1985 and 1997 were evaluated in this study. Informed consent was obtained for these studies from all patients. AML and cALL diagnoses were made by morphological and cytochemical analyses according to conventions of the FAB Cooperative Group.
14,15 CLL diagnosis was based on established hematological criteria and was confirmed by an immuno-phenotypic analysis.
14 Heparinized venous blood was obtained from these patients prior to the start of chemotherapy, and mononuclear cells were separated using FicollHypaque density gradient centrifugation. Selection of patient samples was based on the availability of large cell numbers (Ͼ2 × 10 8 cells) needed to measure the activity and protein expression of protein phosphatase. Samples containing more than 95% leukemic cells were frozen in liquid nitrogen and stored at −80°C until measurements of phosphatase activity. Normal neutrophils were separated from buffy coats of 10 normal healthy donors by Ficoll-Hypaque density gradient centrifugation, and residual erythrocytes were removed by lysis in hypotonic medium. Peripheral blood lymphocytes and monocytes were isolated by Ficoll-Hypaque sedimentation produced leukocyte preparations from buffy coats of 10 normal healthy donors. Lymphocyte purification was achieved by removing monocytes by adherence to glass from the elutriation fraction. Monocytes were isolated with CD14 monoclonal antibody and magnetic Dynabeads (Dynal, Oslo, Norway). The purities of these normal leukocytes were Ͼ90%, as determined by May-Giemsa staining. Surface markers of AML blasts were assessed by cytofluorometry in an immunofluorescence-activated cell sorter (Cytron; Ortho Diagnostic System, Tokyo, Japan) using monoclonal antibodies, including CD11b (OKM1), CD11c (LeuM5), CD13 (MCS2), CD14 (My4), CD33 (My9), CD34 (My10) as myeloid markers, CD7 (WT1 or TP40) as a T cell marker, and CD19 (B4 or Leu12) as a B cell marker. At least 5000 cells were examined for surface marker analysis. 16 The specimen was considered positive for a monoclonal antibody if over 15% of cells showed specific labeling above the control.
Preparation of cytosolic fractions
Leukemic cells (2 × 10 8 cells) disrupted in 500 l of homogenization buffer consisting of 250 mM sucrose and buffer A (20 mM Tris-HCl, pH 7.5, 2 mM dithiothreitol, 5 mM EDTA, 5 mM EGTA, and protease inhibitors, including 75 mg/l phenylmethyl-sulfonylfluoride, 10 mg/l leupeptin, 10 mg/l N-tosyllysine chloromethyl ketone, and 5 mg/l N-tosyl phenylalanine chloromethyl ketone), using a glass to glass PotterElvehjem homogenizer at 4°C. 10, 12 The supernatant was centrifuged at 100 000 g for 1 h to obtain the cytosolic fraction.
Measurement of phosphatase activity
Activities of PP1, PP2A, PP2B and PP2C were determined using 32 P-phosphorylated myosin light chain (MLC) of chicken gizzard as a substrate. PP1 and PP2A activities were measured in a reaction mixture (50 l) containing 20 mM Tris-HCl, pH 7.4, 50 mM NaCl, 0.1 mM EGTA, ± 10 nM OKA and ± a heat stable phosphatase inhibitor-2.
6-9 PP1 can be taken as the activity sensitive to the inhibitor-2 and PP2A can be taken as the activity blocked by 10 nM OKA. PP2B and PP2C activities were determined as the activity in the presence of 0.5 mM CaCl 2 , 5 mm MgCl 2 , 500 nM OKA, 0.1 mg/ml bovine serum albumin, 1 M calmodulin and ± 0.15 mM trifluoperazine. 11, 12 PP1 and PP2A activities were completely inhibited at 500 nM OKA, therefore this activity was taken as the total activity of PP2B and PP2C. PP2B activity was determined by subtracting PP2C (the activity in the presence of 0.15 mM trifluoperazine) from the total activity. Under these conditions, the rates of phosphorylation were linear with respect to time and enzyme dilution. Assays were done in duplicate, and the c.p.m. measured in blank assays lacking cell sample was subtracted from the total c.p.m. The phosphatase activity was indicated as nanomoles released 32 Pi per min in 10 8 cells.
Immunoblot analysis
Immunoblot analysis was carried out using polyclonal antibodies specific against PP1 catalytic subunits (PP1␣, PP1␥, PP1␦), PP2A catalytic subunit, PP2B catalytic subunits (PP2B-A␣ and PP2B-A␤), and PP2C catalytic subunits (PP2C␣ and PP2C␤), as described. [7] [8] [9] [10] [11] [12] [13] The specificity of all immunoreactive proteins has been established by immunoblot analysis. [7] [8] [9] [10] [11] [12] [13] Quantitative estimation of the level of each phosphatase was done densitometrically by scanning the immunoreactive band after immediately photographing the visualized band. [7] [8] [9] [10] [11] [12] [13] The signal was then compared with that of known amounts of each purified recombinant phosphatase. Routinely, at least three different amounts of each phosphatase were included as standards to quantify the level of phosphatase. The amount of each phosphatase was expressed as ng per 10 8 cells.
Statistical analysis
Differences between groups were evaluated by Student's non-parametric t-test, and P Ͻ 0.05 indicated a significant difference.
Results and discussion Figure 1 shows differences in the level of each phosphatase activity in AML (65 cases), cALL (eight cases), and B-CLL (12 cases) and in normal mature leukocytes. AML cases were classified into following subtypes according to French-American-British (FAB) classification: 15 12 M1, 20 M2, 12 M3, 12 M4, 9 M5. Because of the comparatively small number of cases, the AML-M5a and -M5b subclasses were pooled together. PP1 is the most abundant phosphatase among four major Ser/Thr phosphatases in blood cells, and relative abundance of each phosphatase was PP1ϾPP2AϾPP2BԼPP2C. Although there were considerable variations in the level of PP1 activity, even from patients with a similar clinical diagnosis, the level of PP1 activity in AML-M1 and lymphoid leukemic cells from ALL and B-CLL appeared to be lower than that in other types of AML blasts. The distribution of PP2A activity among various types of leukemic blasts was similar to that of PP1 activity. Cases of AML with myelomonocytic features (AML-M4 and -M5) exhibited significantly higher activities of both PP1 and PP2A than the less differentiated cases (AML-M1). PP1 activity of normal monocytes was highest among normal leukocytes and was approximately three times higher than that of normal lymphocytes. PP2A activity was significantly lower in the immature form (AML-M1) of the granulocytic leukemia than in the more differentiated subtypes (AML-M2 and -M3). PP2A activity of neutrophils was significantly lower than that of monocytes or lymphocytes. The distribution of PP2B activity among various types of leukemic blasts differed from that of PP1. PP2B activity was significantly higher in AML-M2 and -M3 blasts than that in AML-M1 or -M5 blasts. PP2B activity of lymphocytes was highest among leukocytes, although this difference did not achieve statistical significance between lymphocytes and monocytes. Lymphoid leukemic cells from cALL and CLL tended to display relatively higher PP2B activity, compared to AML-M1 blasts. PP2C activity was relatively constant among various leukemic cell types, although PP2C activity in monocytic subtype AML-M5 blasts tended to be higher. PP2C activity of monocytes showed the highest activity among normal leukocytes.
Activities of protein phosphatases can be modulated by changes in the levels of activators or inhibitors for a prolonged period or by changes in the levels of functional phosphatases in the cells in response to growth factors and differentiation factors. [1] [2] [3] We next examined amounts of PP1 catalytic subunit isozymes (PP1␣, PP1␥, and PP1␦), PP2A catalytic subunit, PP2B catalytic subunit isozymes (PP2B-A␣, PP2B-A␤), and PP2C catalytic subunit isozymes (PP2C␣, PP2C␤) using a quantitative immunoblot method and respective polyclonal antibodies, [7] [8] [9] [10] [11] [12] [13] as shown in Figure 2 . Our data indicated that 
Figure 2
Expressions of four major phosphatase catalytic subunits in various primary leukemic cells and normal leukocytes. Amounts of PP1, PP2A, PP2B and PP2C catalytic subunits in AML blasts subgrouped according to FAB classification (M1-M5), ALL blasts, CLL cells, normal neutrophils (N), normal lymphocytes (L), normal monocytes (M) were analyzed by immunoblot analysis, using antisera specific for PP1␣ ({), PP1␥ (`), PP1␦ (a), PP2A ({), PP2B-A␣ ({), PP2B-A␤ (`), PP2C␣ () and PP2C␤ (`) as described in Materials and methods. Number of cases is indicated in parenthesis under the cell types. Values are expressed as means (columns) ± s.e. (bars). Student's t-test. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. the total amount of each phosphatase catalytic subunit appeared to correlate with the level of its phosphatase activity in various leukemic cell types (compare Figures 1 and 2 ). All PP1 catalytic subunit isozymes (PP1␣, PP1␥ and PP1␦) were ubiquitously and comparably expressed in most leukemic cell types, whereas the expression of PP1␣ was significantly higher among three PP1 isozymes in normal neutrophils and lymphocytes. Expressions of PP1␣ were prominently increased in AML-M4 blasts and in normal monocytes. PP1␦ was highly expressed in AML-M4, -M5 blasts and in normal monocytes. PP2A enzyme expressions in AML-M4 blasts and in normal monocytes were more abundant than in other cell types. In AML-M1, ALL, and CLL cells, the expression of PP2A was low. The pattern of PP2B-A␣ expression differed from that of PP2B-A␤ expression. In AML-M1, -M2, -M3, CLL cells and normal neutrophils, expression of PP2B-A␣ was more abundant than 598 Table 1 Relationship between activities of four major protein phosphatases and immunophenotypes of AML blasts Results are expressed as the mean ± s.e. * P Ͻ 0.05; **P Ͻ 0.01.
that of PP2B-A␤. In ALL blasts and normal lymphocytes, the amount of PP2B-A␣ expression was similar to that of PP2B-A␤. The lower PP2B activity in neutrophils appeared to be mostly due to the significant lower expression of PP2B-A␤. The amount of PP2B-A␤ enzyme expression in AML-M4, -M5 blasts, and normal monocytes tended to be more abundant than that of PP2-BA␣. In most leukemic cell types and normal leukocytes, PP2C␣ expression was higher than that of PP2C␤. Thus, PP1, PP2A, PP2B and PP2C were ubiquitously but differently expressed in primary leukemic blasts and in normal leukocytes, suggesting that these phosphatases have essential roles in cellular proliferation, differentiation of hematopoietic cells, and in specific functions of different terminal myeloid cells. Although distribution of the total amount of each phosphatase catalytic subunit appeared to parallel that of its activity in various leukemic cell types, our study does not exclude the possibility that other factors may influence the net phosphatase activity. PP1, PP2A and PP2B isolated in various forms from mammalian tissues are composed of catalytic and regulatory subunits. [1] [2] [3] The activity or substrate specificity of these phosphatases may be altered by modification or interaction with regulatory proteins, without change in the level of catalytic subunit expression. Further investigations on these regulatory subunits in various leukemic cells are expected to shed light on the roles of these phosphatases in hematopoietic cells.
Leukemic myeloblasts express a variety of leukocyte differentiation antigens, thereby reflecting commitment to the myeloid lineage, as well as level of maturation. 14 Immunophenotyping has made feasible elucidation of the relationship between the stage of myeloid differentiation and expression of each phosphatase in AML blasts. 14, 17 The analysis was restricted to blast population by gating on forward and side light scatter parameters and excluding the majority of contaminating mature leukocytes. Among the myeloid lineage antibodies, panmyeloid-associated antigens, CD13 and/or CD33 were detected on most AML blasts and did not correlate with FAB classification. Expression of CD34, a marker for myeloid progenitor cells, including stem cells, was high in AML-M1 (four cases positive/seven cases tested), -M2 (12/18) and -M4 (5/9) subtypes and low in AML-M3 (2/8) and -M5 (1/7). The presence of CD34 antigen was more frequently observed in immature FAB subtypes, AML-M1 and -M2. CD11b and CD11c are of a different integrin ␣ subunit that covalently associates with the common ␤2 integrin (CD18) to form heterodimers termed Mac-1 (␣ M ␤2) and p150,90 (␣ x ␤2), respectively.
18 CD11b/CD18 and CD11c/CD18 are critical to monocyte and granulocyte adhesion-dependent functions. 5 While expression of these antigens begins only at the myelocyte stage of granulocyte maturation with highest levels found in mature granulocytes, the antigens are markers of immature monocytes (monoblasts), appearing earlier in monocytic development than the prototype antigen CD14. 5, 18 CD11b was highly positive in AML-M5 (7/7) and -M4 (7/8), reactions The monocyte/macrophage marker, CD14 was frequently expressed in monocytic variant AML-M5 (6/6) and -M4 (3/9), whereas the antigen was rarely expressed in AML-M1 (1/6), -M2 (2/18) and -M3 (0/7) cases. T cell antigen (CD7) was positive in 20% of cases (10/49), this antigen being mainly expressed in AML-M1 (4/7), -M2 (3/18) and -M4 (3/9). B cell antigen (CD19) was only found in six of 18 cases (33%) of AML-M2 blasts. Four major phosphatase activities in relation to various phenotypical markers are shown in Table 1 . Figure  3 summarizes data on the significant correlation between the level of phosphatase activity and positivity of the cell surface marker. CD11b-positive AML cells showed significantly higher activities of both PP1 and PP2A than those of CD11b-negative AML cells. Correlation coefficients between CD11b positivity and PP1 or PP2A activity were 0.704 and 0.529 (P Ͻ 0.05), respectively. No significant difference in each phosphatase activity was demonstrated between CD11c-positive and -negative cells, or between CD13-positive and -negative cells. The CD14-positive AML cells showed significantly higher PP2A activity than did CD14-negative cells. The correlation coefficient between CD14 positivity and PP2A activity was 0.412 (P Ͻ 0.05). PP1 activity of the stem cell marker CD34-positive AML blasts tended to be lower than that of CD34-negative blasts, but the level of PP1 activity of AML blasts showed a negative correlation with CD34 positivity (r = −0.588, P Ͻ 0.05). There was no significant difference in each phosphatase activity between CD19-positive and -negative AML blasts. Interestingly, in AML-M2 blasts associated with B-lymphoid leukemic antigen (CD19), PP2B activity tended to be higher than that observed in AML blasts lacking CD19, and was similar to that in lymphoid leukemic cells such as ALL and CLL. The CD7-positive AML blasts had significantly lower activities of PP1, PP2A and PP2B than those of blasts without such surface antigen. These findings suggest that T cell antigen-positive and B cell antigen-positive AML blasts might have different biologic features. The correlation coefficients between CD7 positivity of AML blasts and activity of PP1, PP2A or PP2B were −0.661, −0.276, or −0.475 (P Ͻ 0.05), respectively. Such CD7-positive AML blasts may arise from malignant transformation of early progenitor cells capable of differentiating into more than one lineage. 16, 19 These findings suggest that the levels of PP1, PP2A and PP2B activities are relatively low in leukemic cells which are considered to be morphologically and immunophenotypically immature and that each phosphatase activity is differently modulated during the course of myelomonocytic cell differentiation.
Our earlier studies revealed that expression of each protein phosphatase, including PP1, PP2A, PP2B and PP2C, is differ-ently regulated during differentiation of HL-60 cells, [6] [7] [8] [9] [10] [11] [12] [13] and this present study is the first that provides a detailed analysis of four major protein phosphatases in primary human leukemic cells and in normal peripheral leukocytes. Our study indicates that four major phosphatases are ubiquitously but differently expressed in various types of leukemic cells and in normal mature leukocytes. Although the exact mechanism of different expression of each phosphatase is unknown, there is evidence that the regulation may be at the level of RNA transcription, rather than mRNA stabilization or protein turnover. Our reported data demonstrated that alterations in phosphatase expression during HL-60 cell differentiation correlate with the level of phosphatase mRNA. [7] [8] [9] 11, 12 Expressions of PP1, PP2A and PP2B appear to be relatively low in leukemic blasts arresting at the stage of early pluripotent stem cells, and each phosphatase may be differently modulated during the course of myelomonocytic commitment and maturation. Thus, the differential modulation of protein phosphatase expressions may have an important role in regulating the phosphorylation of critical substrates that subsequently mediate the differentiation or maturation of hematopoietic cells.
